To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;; Rhabdomyosarcoma;; Ewing's Sarcoma;; Ewing's Tumor;; Sarcoma, Ewing's;; Sarcomas, Epitheliod;; Sarcoma, Soft Tissue;; Sarcoma, Spindle Cell;; Melanoma;; Malignant Melanoma;; Clinical Oncology;; Oncology, Medical;; Pediatrics, Osteosarcoma;; Osteogenic Sarcoma;; Osteosarcoma Tumor;; Sarcoma, Osteogenic;; Tumors;; Cancer;; Neoplasia;; Neoplasm;; Histiocytoma;; Fibrosarcoma;; DermatofibrosarcomaIntervention: Drug: nab-paclitaxelSponsor: Celgene CorporationRecruiting - verified April 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Cancer | Cancer & Oncology | Dermatology | Fibrosarcoma | Melanoma | Neuroblastoma | Neurology | Osteosarcoma | Pediatrics | Research | Rhabdomyosarcoma | Sarcomas | Skin Cancer | Soft Tissue Sarcoma